Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifshitz Law PLLC Announces Investigations of Beyond Meat, Inc. (NASDAQ:BYND), and BellRing Brands, Inc. (NYSE: BRBR), Vistagen Therapeutics, Inc. (NASDAQ:VTGN), and CoreWeave, Inc. (NASDAQ:CRWV)

accessnewswire.com
BYND The company is under investigation for potentially making false and misleading statements regarding its book value and asset impairment, which could impact its ability to file timely reports. BRBR Investigation into allegations of misleading statements about sales, failing to disclose that strong results were due to customer inventory buildup rather than demand, and subsequent weakening demand due to competitive pressures. VTGN The company is being investigated for allegedly making misleading statements about fasedienol's prospects and concealing adverse data from a key clinical trial, despite positive public statements. CRWV Investigation into allegations of overstating demand fulfillment capabilities and understating risks associated with a single data center supplier, potentially impacting revenue.

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2026 / Beyond Meat, Inc. (NASDAQ:BYND)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the book value of certain of Beyond Meat's long-lived assets exceeded their fair value, making it highly likely that the Company would be required to record a material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the U.S. Securities and Exchange Commission; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a BYND investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

BellRing Brands, Inc. (NYSE:BRBR)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company failed to disclose to investors that its strong sales results did not reflect increased end-consumer demands or brand momentum; (ii) rather, customers accumulated excess inventory as a safeguard against product shortages that had previously constrained BellRing's supply; (iii) once customers gained confidence that product shortages were a thing of the past, they promptly reduced their inventory by selling through existing products and cutting back on new orders; and (iv) following the destocking, the Company admitted that competitive pressures were materially weakening demand.

If you are a BRBR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Vistagen Therapeutics, Inc. (NASDAQ:VTGN)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company provided overwhelmingly positive statements to investors regarding the development and prospects of fasedienol, despite the fact that the Company's Phase 3 PALISADE‑3 trial of the investigational pherine candidate for the acute treatment of social anxiety disorder was beset by materially adverse facts; (ii) the Company disseminated false and misleading information and/or concealed material adverse data concerning the PALISADE‑3 study's design, execution, and clinical results; and (iii) as a result, the Company's statements about Vistagen's business, operations, and prospects were materially false and misleading at all relevant times.

If you are a VTGN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

CoreWeave, Inc. (NASDAQ:CRWV)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated CoreWeave's ability to meet customer demand for its service; (ii) the Company materially understated the scope and severity of the risk that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company's revenue; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a CRWV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE: Lifshitz Law Firm